Digestive & Intestinal Remedies (Pharmacies) - Russia

  • Russia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$206.10m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.91%, resulting in a market volume of US$222.30m by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.43 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Russia is experiencing steady growth due to changing customer preferences and favorable macroeconomic factors.

Customer preferences:
In recent years, there has been an increasing demand for digestive and intestinal remedies in Russia. This can be attributed to several factors. Firstly, there is a growing awareness among consumers about the importance of digestive health and the role it plays in overall wellness. As a result, more people are seeking remedies to address common digestive issues such as indigestion, bloating, and constipation. Secondly, the hectic and stressful lifestyles of modern Russians have led to a rise in digestive problems, creating a need for effective remedies. Lastly, the aging population in Russia is also contributing to the demand for digestive and intestinal remedies, as older individuals are more prone to digestive issues.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Russia is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives to synthetic medications. This trend is driven by a desire for safer and more sustainable options. As a result, there has been a rise in the availability and sales of herbal supplements and remedies targeting digestive health. Additionally, there is a growing trend towards self-care and self-medication, with consumers seeking over-the-counter remedies for minor digestive issues instead of visiting healthcare professionals.

Local special circumstances:
Russia has a unique healthcare system that influences the Digestive & Intestinal Remedies market. The country has a strong tradition of self-medication, with consumers often relying on pharmacies for advice and purchasing remedies without a prescription. This has created a favorable environment for the growth of the over-the-counter market for digestive and intestinal remedies. Additionally, the Russian market is characterized by a high level of competition, with both domestic and international players vying for market share. This competition has led to innovation in product offerings and marketing strategies to attract and retain customers.

Underlying macroeconomic factors:
The Digestive & Intestinal Remedies market in Russia is also influenced by macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income and consumer spending. As a result, consumers have more purchasing power and are willing to spend on healthcare products, including digestive and intestinal remedies. Furthermore, the government has implemented healthcare reforms that have improved access to healthcare services and medications, further driving the demand for remedies in the market. In conclusion, the Digestive & Intestinal Remedies market in Russia is growing due to changing customer preferences, including a demand for natural remedies and a trend towards self-medication. The local special circumstances, such as the tradition of self-medication and high competition, also contribute to the market's development. Additionally, favorable macroeconomic factors, such as economic growth and healthcare reforms, have created a conducive environment for the market's growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)